Condition: Advanced Malignant Tumors · Sponsor: Bristol-Myers Squibb
This purpose of this study is to determine if experimental treatment with BMS-986488, alone, or in combinations is safe, tolerable, and has anti-cancer activity in patients with advanced malignant tumors.
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain NCT # and Site #.
Always discuss trial participation with your own doctor first.
| John Theurer Cancer Center at Hackensack University Medical Center | Hackensack, New Jersey, United States | Recruiting |
| Local Institution - 0020 | Allentown, Pennsylvania, United States | Active Not Recruiting |
| The West Clinic, PLLC dba West Cancer Center | Germantown, Tennessee, United States | Recruiting |
| Local Institution - 0025 | Dallas, Texas, United States | Withdrawn |
| Local Institution - 0031 | Brisbane, Queensland, Australia | Active Not Recruiting |
| Local Institution - 0032 | Vancouver, British Columbia, Canada | Active Not Recruiting |
| Local Institution - 0015 | Montreal, Quebec, Canada | Not Yet Recruiting |
| Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus | Québec, Quebec, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06764771